Iterum Therapeutics (ITRM) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Iterum Therapeutics

    NASDAQ: ITRM · Real-Time Price · USD
    0.67
    0.00 (0.04%)
    At close: Oct 03, 2025, 3:59 PM
    0.71
    5.84%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    Iterum Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.41 -0.67 -0.23 -0.7
    PEG Ratio
    		 0.02 0.04 0.00 0.01
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 -8.54 -3.99 0.37 1.27
    P/FCF Ratio
    		 -1.3 -0.65 -0.55 -4.03
    P/OCF Ratio
    		 -1.3 -0.65 -0.56 -4.04
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 -11.16 -2.96 1.02 0.50
    Quick Ratio
    		 1.41 1.89 319.84 13.94
    Current Ratio
    		 1.41 1.89 310.40 13.43
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a -33.24 -12.87 -4.42
    Return on Equity
    		 6.07 5.99 -1.59 -1.82
    Return on Assets
    		 -0.56 -1.46 -0.66 -1
    Return on Invested Capital
    		 -0.46 -3.79 -0.46 -0.28
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist